InsiderTrades

Form 4 for MRNA Moderna

Accepted 2022-07-14 00:00:00 ET · period of report 2022-07-12 · accession 0001127602-22-019300 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-07-14 2022-07-12+ MRNA Hoge Stephen Pres M - OptEx $10.90 +10.0K 1.63M +0.6% +$109.0K
DM 2022-07-14 2022-07-12+ MRNA Hoge Stephen Pres S - Sale+OE $171.81 -10.0K 1.62M -0.6% -$1.72M
DM 2022-07-14 2022-07-12+ MRNA Hoge Stephen Pres M - OptEx $0.00 -10.0K 37.0K -21% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-07-12 M A 5,000 $10.90 1,629,231 D — —
2 Common Common Stock 2022-07-12 S D 5,000 $174.73 1,624,231 D — —
3 Common Common Stock 2022-07-13 M A 5,000 $10.90 1,629,231 D — —
4 Common Common Stock 2022-07-13 S D 5,000 $168.88 1,624,231 D — —
5 Derivative Stock Option (Right to Buy) 2022-07-12 M D 5,000 $0.00 41,972 D $10.90 · — to 2026-02-23 5,000 Common Stock (F3) This option is fully vested and exercisable.
6 Derivative Stock Option (Right to Buy) 2022-07-13 M D 5,000 $0.00 36,972 D $10.90 · — to 2026-02-23 5,000 Common Stock (F3) This option is fully vested and exercisable.